GATA2 and adenoviridae infectious disease: Specifically, the rate of infectious complications (cytomegalovirus reactivation, cytomegalovirus disease, Epstein–Barr virus infections/post-transplant lymphoproliferative disorder, adenovirus infections, viral, bacterial, fungal, and parasitic infections) was 66% in the GATA2 deficient patients and 61% in the control group [7].